Volume | 4,734 |
|
|||||
News | - | ||||||
Day High | 15.12 | Low High |
|||||
Day Low | 14.54 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Curis Inc | CRIS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
15.12 | 14.54 | 15.12 | 14.77 | 15.01 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
161 | 4,734 | $ 14.74 | $ 69,786 | - | 3.80 - 19.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 789 | $ 14.77 | USD |
Curis Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
86.64M | 5.89M | - | 10.02M | -47.41M | -8.04 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Curis News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.49 | 16.50 | 14.06 | 15.31 | 18,620 | -0.72 | -4.65% |
1 Month | 10.14 | 17.49 | 10.08 | 15.02 | 41,898 | 4.63 | 45.66% |
3 Months | 10.00 | 17.49 | 8.24 | 12.06 | 33,272 | 4.77 | 47.70% |
6 Months | 4.06 | 17.49 | 3.80 | 10.27 | 63,908 | 10.71 | 263.79% |
1 Year | 16.60 | 19.60 | 3.80 | 13.44 | 167,430 | -1.83 | -11.02% |
3 Years | 211.40 | 348.00 | 3.80 | 87.97 | 1,401,221 | -196.63 | -93.01% |
5 Years | 36.20 | 348.00 | 3.80 | 96.82 | 1,571,733 | -21.43 | -59.20% |
Curis Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |